Urinary and genital infections in patients with diabetes: How to diagnose and how to treat.

P Njomnang Soh, F Vidal, E Huyghe, P Gourdy, J M Halimi, B Bouhanick

Journal: Diabetes & metabolism 2016;42(1):16-24

PMID: 26323665

Abstract

Diabetes is a predisposing factor for urinary tract and genital infections in both women and men. Sodium-glucose cotransporter-2 (SGLT2) inhibitors constitute a novel therapeutic class indicated for type 2 diabetes (T2D) patients, and are already on the market in a few countries in Europe. They decrease glycaemia mainly by enhancing glucose excretion in urine by reducing renal glucose reabsorption via the action of SGLT2 in the kidneys. In general, they are well tolerated, but their mode of action results in specific side effects as well as an increased risk of genital (vulvovaginitis and balanitis) and urinary tract infections, for which T2D patients are already at high risk, reported within the first 6 months of treatment. Usually these infectious events are successfully treated with standard therapies, but diabetologists are not accustomed to dealing with them. The aim of this review is to describe the different types of lower urinary tract and genital infections, and the treatment strategies currently available for patients with diabetes.

Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Address: Groupe de Recherche en Fertilité Humaine EA 3694, Université Paul-Sabatier, 31059 Toulouse, France. Electronic address: [email protected].; Département de gynécologie obstétrique, CHU Purpan, 1, place Baylac, 31059 Toulouse, France. Electronic address: [email protected].; Service d'Urologie, CHU Rangueil, 1, avenue J.-Poulhes, 31059 Toulouse cedex 9, France. Electronic address: [email protected].; Service de Diabétologie, CHU Rangueil, 1, avenue J.-Poulhes, 31059 Toulouse cedex 9, France. Electronic address: [email protected].; Service de Néphrologie, CHU de Tours, 37044 Tours cedex, France. Electronic address: [email protected].; Service de Médecine Interne et HTA, Pôle CardioVasculaire et Métabolique, CHU Rangueil, TSA 50032, 31059 Toulouse cedex 9, France. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.